ECHO Powers On the Fight Against Breast Cancer with Susan G. Komen®
September 19, 2024 14:00 ET
|
ECHO Incorporated
Lake Zurich, Illinois, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ECHO Incorporated, a ECHO Incorporated, a leading manufacturer of professional-grade, high-performance outdoor power equipment for...
Dickey’s Barbecue Bringing Back Their Pink Big Yellow Cup to Support Breast Cancer Awareness
September 18, 2024 08:00 ET
|
Dickey’s Barbecue Restaurants
Dallas, TX, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Dickey’s Barbecue Pit is once again joining the fight against breast cancer this October with the return of their popular limited-edition Pink Big...
Breast Cancer Therapy Market is Estimated to be USD 63.13 Billion by 2032 with a CAGR of 8.5% | Polaris Market Research
September 13, 2024 08:00 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global breast cancer therapy market size is predicted to grow from USD 30.90 billion in 2023 to USD 63.13 billion by 2032....
Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
September 10, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced its support of the U.S. Food and Drug Administration (FDA) for...
Europe Breast Cancer Screening Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Novartis, Sanofi, Pfizer, Bayer, and GlaxoSmithKline
September 04, 2024 10:39 ET
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market Forecast Report by Europe Breast Cancer Screening Market, Countries, and Company Analysis, 2024-2032" report has...
Arvinas to Participate in Upcoming Investor Conferences
August 29, 2024 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Sermonix Pharmaceuticals Completes Enrollment of Phase 2 I-SPY 2 Arm Evaluating Lasofoxifene in Neoadjuvant Breast Cancer Setting
August 27, 2024 09:00 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio and SAN FRANCISCO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat...
Companion Diagnostics Market Size to Hit USD 9.3 Billion Revenue by 2028 with 9% CAGR: Report by Transparency Market Research
August 20, 2024 10:38 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 20, 2024 (GLOBE NEWSWIRE) -- The global companion diagnostics market (동반진단 시장) was worth US$ 5.2 Bn in 2020 and is...
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 12, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
Presented data showing 100% disease control rate after 24-week treatment with (Z)-Endoxifen in 40mg cohort of Phase 2 EVANGELINE study at the American Association for Cancer Research (AACR) Annual...
Elucent Medical Announces Froedtert & the Medical College of Wisconsin Health Network to Provide New Breast Cancer Surgical Technology
August 09, 2024 08:00 ET
|
Elucent
EDEN PRAIRIE, Minn., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Elucent Medical, a pioneering medical technology company transforming the field of guided surgical technology, is thrilled to announce...